Given that IL-6 and IL-8 expression induced by acid may lead to mucosal injury in GERD, thus inhibition of the pro-inflammatory cytokine pathways like NF-kB may act as an important therapeutic target for treating esophageal inflammation. The gene discussed is CXCL8; the disease is gastroesophageal reflux disease.